371 related articles for article (PubMed ID: 27835923)
1. Reactive Oxygen Species/Nitric Oxide Mediated Inter-Organ Communication in Skeletal Muscle Wasting Diseases.
Leitner LM; Wilson RJ; Yan Z; Gödecke A
Antioxid Redox Signal; 2017 May; 26(13):700-717. PubMed ID: 27835923
[TBL] [Abstract][Full Text] [Related]
2. Pro-cachectic factors link experimental and human chronic kidney disease to skeletal muscle wasting programs.
Solagna F; Tezze C; Lindenmeyer MT; Lu S; Wu G; Liu S; Zhao Y; Mitchell R; Meyer C; Omairi S; Kilic T; Paolini A; Ritvos O; Pasternack A; Matsakas A; Kylies D; Wiesch JSZ; Turner JE; Wanner N; Nair V; Eichinger F; Menon R; Martin IV; Klinkhammer BM; Hoxha E; Cohen CD; Tharaux PL; Boor P; Ostendorf T; Kretzler M; Sandri M; Kretz O; Puelles VG; Patel K; Huber TB
J Clin Invest; 2021 Jun; 131(11):. PubMed ID: 34060483
[TBL] [Abstract][Full Text] [Related]
3. Myostatin: more than just a regulator of muscle mass.
Argilés JM; Orpí M; Busquets S; López-Soriano FJ
Drug Discov Today; 2012 Jul; 17(13-14):702-9. PubMed ID: 22342983
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms to explain wasting of muscle and fat in cancer cachexia.
Argilés JM; López-Soriano FJ; Busquets S
Curr Opin Support Palliat Care; 2007 Dec; 1(4):293-8. PubMed ID: 18685378
[TBL] [Abstract][Full Text] [Related]
5. Emerging therapies for the treatment of skeletal muscle wasting in chronic obstructive pulmonary disease.
Passey SL; Hansen MJ; Bozinovski S; McDonald CF; Holland AE; Vlahos R
Pharmacol Ther; 2016 Oct; 166():56-70. PubMed ID: 27373503
[TBL] [Abstract][Full Text] [Related]
6. Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting.
Song YH; Li Y; Du J; Mitch WE; Rosenthal N; Delafontaine P
J Clin Invest; 2005 Feb; 115(2):451-8. PubMed ID: 15650772
[TBL] [Abstract][Full Text] [Related]
7. The role of beta-adrenoceptor signaling in skeletal muscle: therapeutic implications for muscle wasting disorders.
Koopman R; Ryall JG; Church JE; Lynch GS
Curr Opin Clin Nutr Metab Care; 2009 Nov; 12(6):601-6. PubMed ID: 19741516
[TBL] [Abstract][Full Text] [Related]
8. The biological mechanisms of cancer-related skeletal muscle wasting: the role of progressive resistance exercise.
Al-Majid S; Waters H
Biol Res Nurs; 2008 Jul; 10(1):7-20. PubMed ID: 18705151
[TBL] [Abstract][Full Text] [Related]
9. Exogenous GDF11 induces cardiac and skeletal muscle dysfunction and wasting.
Zimmers TA; Jiang Y; Wang M; Liang TW; Rupert JE; Au ED; Marino FE; Couch ME; Koniaris LG
Basic Res Cardiol; 2017 Jul; 112(4):48. PubMed ID: 28647906
[TBL] [Abstract][Full Text] [Related]
10. Sarcopenia in Chronic Kidney Disease: Factors, Mechanisms, and Therapeutic Interventions.
Watanabe H; Enoki Y; Maruyama T
Biol Pharm Bull; 2019; 42(9):1437-1445. PubMed ID: 31474705
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor type beta (TGF-β) requires reactive oxygen species to induce skeletal muscle atrophy.
Abrigo J; Rivera JC; Simon F; Cabrera D; Cabello-Verrugio C
Cell Signal; 2016 May; 28(5):366-376. PubMed ID: 26825874
[TBL] [Abstract][Full Text] [Related]
12. Nuclear factor erythroid-derived 2-like 2 (NFE2L2, Nrf2) mediates exercise-induced mitochondrial biogenesis and the anti-oxidant response in mice.
Merry TL; Ristow M
J Physiol; 2016 Sep; 594(18):5195-207. PubMed ID: 27094017
[TBL] [Abstract][Full Text] [Related]
13. The Redox Balance: A Target for Interventions Against Muscle Wasting in Cancer Cachexia?
Penna F; Ballarò R; Costelli P
Antioxid Redox Signal; 2020 Sep; 33(8):542-558. PubMed ID: 32037856
[No Abstract] [Full Text] [Related]
14. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress, chronic disease, and muscle wasting.
Moylan JS; Reid MB
Muscle Nerve; 2007 Apr; 35(4):411-29. PubMed ID: 17266144
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness.
Chacon-Cabrera A; Fermoselle C; Urtreger AJ; Mateu-Jimenez M; Diament MJ; de Kier Joffé ED; Sandri M; Barreiro E
J Cell Physiol; 2014 Nov; 229(11):1660-72. PubMed ID: 24615622
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress, redox signaling pathways, and autophagy in cachectic muscles of male patients with advanced COPD and lung cancer.
Puig-Vilanova E; Rodriguez DA; Lloreta J; Ausin P; Pascual-Guardia S; Broquetas J; Roca J; Gea J; Barreiro E
Free Radic Biol Med; 2015 Feb; 79():91-108. PubMed ID: 25464271
[TBL] [Abstract][Full Text] [Related]
18. NADPH oxidase hyperactivity induces plantaris atrophy in heart failure rats.
Bechara LR; Moreira JB; Jannig PR; Voltarelli VA; Dourado PM; Vasconcelos AR; Scavone C; Ramires PR; Brum PC
Int J Cardiol; 2014 Aug; 175(3):499-507. PubMed ID: 25023789
[TBL] [Abstract][Full Text] [Related]
19. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation.
Anker SD; Coats AJ
Chest; 1999 Mar; 115(3):836-47. PubMed ID: 10084500
[TBL] [Abstract][Full Text] [Related]
20. Site of mitochondrial reactive oxygen species production in skeletal muscle of chronic obstructive pulmonary disease and its relationship with exercise oxidative stress.
Puente-Maestu L; Tejedor A; Lázaro A; de Miguel J; Alvarez-Sala L; González-Aragoneses F; Simón C; Agustí A
Am J Respir Cell Mol Biol; 2012 Sep; 47(3):358-62. PubMed ID: 22493009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
